Evaluation of the Role of Low Dose Magnesium Sulfate in Anesthesia for Toxic Goiter Resection

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

January 20, 2022

Study Completion Date

January 30, 2022

Conditions
Haemodynamic Stability
Interventions
DRUG

MgSO4

Group (M) n=30 will receive Mg So4 pre-induction as an intravenous bolus 20mg/kg over 10 minutes and maintenance dose intraoperative 5/mg/kg/h intravenous and discontinued just before the end of the surgery. Group (S) n=30 will receive saline in equal volume. The surgeon , anesthesiologist and the person who will collect the data will be blinded for the prepared solution. The solution will be prepared by an expert anesthesia nurse.

Trial Locations (1)

63512

Atef, Al Fayyum

All Listed Sponsors
lead

Fayoum University Hospital

OTHER

NCT04632524 - Evaluation of the Role of Low Dose Magnesium Sulfate in Anesthesia for Toxic Goiter Resection | Biotech Hunter | Biotech Hunter